Skip to content

Abre™ AB9U18080090Recalls & reported problems

Medtronic, Inc. · STENT AB9U18080090 ABRE V01 · Class 3 · Implant

All models of Abre (26)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169796393), received between Oct 17, 2022 and Feb 7, 2025 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).

3 other recalls cover devices cleared under the same FDA submission (P200026); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation, Positioning or Separation Problem1
  • Malposition of Device1
  • Material Deformation1
  • Premature Activation1
  • Use of Device Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 7, 2025Premature Activation; Activation, Positioning or Separation Problem; Premature Activation; Activation, Positioning or Separation Problem

    IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING THE ABRE STENT, THERE WERE DEPLOYMENT ISSUES AS THE DEVICE WAS UNABLE TO DEPLOY. THE STENT STRUTS WERE EXPOSED AND VISIBLE UPON REMOVAL. THE EVENT WAS ASSOCIATED WITH A FIBROUS LESION LOCATED IN THE PERIPHERAL VEIN, SPECIFICALLY THE COMMON ILIAC VEIN. THE VESSEL WAS POST-DILATED, AND THE DEVICE WAS SAFELY REMOVED WITHOUT REQUIRING ANY INTERVENTION. THE PROCEDURE WAS COMPLETED USING A NEW ABRE DEVICE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21332828 ↗
  • MalfunctionNov 7, 2024Use of Device Problem; Use of Device Problem

    LIMITED INFORMATION REPORTS THAT AN ABRE STENT WAS IMPLANTED >3MONTHS PAST ITS EXPIRY DATE. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20629183 ↗
  • InjuryOct 17, 2022Malposition of Device; Material Deformation; Malposition of Device; Material Deformation

    A PHYSICIAN WAS IMPLANTING AN ABRE SELF-EXPANDING STENT FOR THE TREATMENT OF UNKNOWN LESION IN THE LEFT ILIAC VEIN. THE VEIN HAD MILD TORTUOSITY. THE PATIENT HAD HARDWARE IMPEDING ON VEIN. A 9FR NON-MDT SHEATH AND A NON-MDT GUIDEWIRE WERE USED. THE DEVICE WAS PREPPED AS PER THE IFU WITH NO ISSUES IDENTIFIED. THE PHYSICIAN VISUALIZED THE MID COMMON ILIAC STENOSIS WITH IVUS AND PRE-DILATED THE VESSEL THE STENT WAS DEPLOYED AND THE VESSEL WAS POST-DILATED. IT WAS REPORTED THAT STENT DEFORMATION OCCURRED POST DEPLOYMENT AND THE STENT WAS DEPLOYED AT AN UNINTENDED LESION SITE. ANOTHER ABRE STENT WAS PREPPED FOR DEPLOYMENT WITH NO ISSUES IDENTIFIED. IT WAS REPORTED THE DEVICE BROKE AT THE MID POINT OF THE STENT DURING DELIVERY THROUGH THE VESSEL. THE PATIENT WAS PRESCRIBED BLOOD THINNERS AND A CT WAS ORDERED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15613636 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P200026. One submission often covers many models, so check the product and lot details in each record.

  • Z-1098-2026 · Dec 4, 2025 · Open, Classified
    Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G12100090 AB9G14080090 AB9G12080090 AB9U12060090 AB9U14100090 AB9U14080090 AB9U12080090 AB9U14060090 AB9G1410
  • Z-0464-2022 · Nov 19, 2021 · Terminated
    Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.
  • Z-1532-2021 · Mar 16, 2021 · Terminated
    Medtronic Abre Venous Self-expanding Sent System, Catalog number REF AB9U16080090 - Product Usage: intended for use in the iliofemoral veins for the treatment of symptomatic venous

Other Stent, iliac vein devices

All Stent, iliac vein devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page